ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Breast Carcinoma
Interventions: DRUG: ACY-1215|DRUG: Nab-paclitaxel
Sponsor: Columbia University
Collaborators: Acetylon Pharmaceuticals Incorporated|National Cancer Institute (NCI)